Media Kit

The Recursion Media Kit provides key materials for journalists to use when covering the Company. Please contact our communications team if you need more information or to schedule an interview.

media@recursion.com

Approved company description

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.

Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area.

Meet our leaders

Chris Gibson, Ph.D.

Co-Founder and CEO
View Bio

Erica Fox

Chief People and Impact Officer
View Bio

David Hallett, Ph.D.

Chief Scientific Officer
View Bio

Nathan Hatfield, MBA, J.D.

Chief Legal Officer & General Counsel
View Bio

Najat Khan, Ph.D.

Chief R&D Officer and Chief Commercial Officer
View Bio

Matt Kinn, MBA

Chief Business Officer
View Bio

Ben Mabey, M.S.

Chief Technology Officer
View Bio

David Mauro, M.D., Ph.D.

Chief Medical Officer
View Bio

Lina Nilsson, Ph.D.

Chief Platform Officer
View Bio

Kristen Rushton, MBA

Chief Operations Officer
View Bio

Ben Taylor

Chief Financial Officer & President Recursion UK
View Bio

Press contact

© 2025 Recursion. All rights reserved.